A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma
Clinical trial NCT05749042 · UNKNOWN
Trial details
- NCT number
- NCT05749042
- Sponsor
- Xin-Hua Xu
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-18
- Primary completion
- 2025-01-18
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.